UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. )*
Biomerica, Inc.
--------------------------------------------------------------------------------
(Name of Issuer)
Common
--------------------------------------------------------------------------------
(Title of Class of Securities)
09061H 30 7
--------------------------------------------------------------------------------
(CUSIP Number)
Janet Moore, 1533 Monrovia Ave., Newport Beach, CA 92663
--------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
May 31, 2006
--------------------------------------------------------------------------------
(Date of Event which Requires Filing of This Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of ss. 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the
following box [_].
Note: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See ss. 240.13d-7(b) for other
parties to whom copies are to be sent.
* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 or otherwise subject to the liabilities of that section of the Act but
shall be subject to all other provisions of the Act (however, see the Notes).
CUSIP No. 09061H 30 7
--------------------------------------------------------------------------------
1. Name of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
Zackary Irani, 1533 Monrovia Ave., Newport Beach, CA 92663, CEO Biomerica
--------------------------------------------------------------------------------
2. Check the Appropriate Box If a Member of a Group (See Instructions)
(a) [_]
(b) [_]
--------------------------------------------------------------------------------
3. SEC Use Only
--------------------------------------------------------------------------------
4. Source of Funds (See Instructions)
PF
--------------------------------------------------------------------------------
5. Check If Disclosure of Legal Proceedings Is Required Pursuant to
Items 2(d) or 2(e) [_]
--------------------------------------------------------------------------------
6. Citizenship or Place of Organization
USA
--------------------------------------------------------------------------------
7. Sole Voting Power
NUMBER OF Number of shares: 323,526 shares of common stock plus
SHARES 412,333 shares underlying an equivalent number of stock
BENEFICIALLY options/warrants exercisable at or within 60 days of this
OWNED BY filing
EACH ----------------------------------------------------------------
REPORTING 8. Shared Voting Power
PERSON
WITH ----------------------------------------------------------------
9. Sole Dispositive Power
----------------------------------------------------------------
10. Shared Dispositive Power
--------------------------------------------------------------------------------
11. Aggregate Amount Beneficially Owned by Each Reporting Person
323,526 shares of common stock and 412,333 shares underlying an
equivalent number of stock options/warrants exercisable at or within
60 days of this filing
--------------------------------------------------------------------------------
12. Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares
(See Instructions) [_]
--------------------------------------------------------------------------------
13. Percent of Class Represented by Amount in Row (11)
11.6%
--------------------------------------------------------------------------------
14. Type of Reporting Person (See Instructions)
IN
--------------------------------------------------------------------------------
ITEM 1. SECURITY AND ISSUER
(a) Name of Issuer:
Biomerica, Inc.
(b) Address of Issuer's Principal Executive Office:
1533 Monrovia Ave.
Newport Beach, CA 92663
ITEM 2. IDENTITY AND BACKGROUND
(a) Name of Person Filing:
Zackary S. Irani
(b) Business address:
1533 Monrovia Ave.
Newport Beach, CA 92663
(c) Principal Occupation:
Chief Executive Officer, Biomerica, Inc.
(d) Criminal Proceedings:
None
(e) Civil Proceedings:
None
(f) Citizenship:
USA
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION
The filer has accumulated issuer's stock over the years through various
transactions including private placements, payment by the Company for services
rendered, open market purchases and stock option grants.
ITEM 4. PURPOSE OF TRANSACTION
Long-term investment and ownership in the Company of which the filer
is CEO.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER
(a) Aggregate number and percentage of the class owned by filer:
Common stock outstanding: 5,922,681 common
Percentage owned by filer: 11.6%
(b) Sole dispositive power of filer:
323,526 shares of common stock and 412,333 shares underlying an
equivalent number of options/warrants exercisable at or within 60 days
of this filing
(c) Transactions in the class of securities reported on that were
effected during the past sixty days: None
(d) Any other person known to have the right to receive or the power
to direct the receipt of dividends: None
(e) If applicable, state the date on which the reporting person ceased
to be the beneficial owner of more than five percent of the class of
securities. Not applicable.
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO
SECURITIES OF THE ISSUER
None
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS
None
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
June 13, 2006
----------------
Date
/s/ Zackary S. Irani
-----------------------------
Signature
Zackary S. Irani
----------------------------------
Name/Title
The original statement shall be signed by each person on whose behalf the
statement is filed or his authorized representative. If the statement is signed
on behalf of a person by his authorized representative (other than an executive
officer or general partner of the filing person), evidence of the
representative's authority to sign on behalf of such person shall be filed with
the statement: provided, however, that a power of attorney for this purpose
which is already on file with the Commission may be incorporated by reference.
The name and any title of each person who signs the statement shall be typed or
printed beneath his signature.
ATTENTION: INTENTIONAL MISSTATEMENTS OR OMISSIONS OF FACT CONSTITUTE FEDERAL
CRIMINAL VIOLATIONS (SEE 18 U.S.C. 1001)